Search Results

1 - 4 of 4 items :

  • European Union x
  • Clinical Medicine x
  • Clinical Medicine, other x
  • Basic Medical Science x
Clear All

REFERENCES 1. Kaakoush N, Castaño-Rodríguez N, Mitchell HM, et al. Global epidemiology of Campylobacter infection. Clin Microbiol Rev 2015; 28(3): 687–720. 2. EFSA, (European Food Safety Authority), ECDC (European Centre for Disease Prevention and Control), 2013. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2011. EFSA Journal 2013; 11(4): 3129, 250 pp. 3. CDC, (Centers for Disease Control and Prevention). Preliminary Food Net data on the incidence of infection with pathogens transmitted commonly

. Roderick P, Roth M, Mindell J. "Prevalence of Chronic Kidney Disease in England: Findings from the 2009 Health Survey for England". Journal of Epidemiology and Community Health. 2011ч 65 (Suppl II): A12 4. Zoccali C, Kramer A, & Jager K. J. "Chronic Kidney Disease and End-stage Renal Disease - a review produced to contribute to the report". The status of health in the European Union: towards a healthier Europe. Nephrology Dialysis Transplantation. 2010; 3: 213-224. 5. Heiwe S, & Jacobson S. H. "Exercise training for adults with Chronic Kidney Disease". Cochrane Database

author: Prof. Momir Polenakovic, MD, PhD, Macedonia Academy of Sciences and Arts, Bul. Krste Misirkov, No. 2, 1000 Skopje, Republic of Macedonia; E-mail 1 University Children’s Hospital Medical School, Skopje, Republic of Macedonia 2 Macedonian Academy of Science and Arts, Skopje, Republic of Macedonia Zoran Gucev1, Velibor Tasic1, Momir Polenakovic2 THE 6TH RARE DISEASE SOUTH EASTERN EUROPE (SEE) MEETING, SKOPJE, MACEDONIA (NOVEMBER 11TH, 2017) The Sixth Conference on Rare Disease in South Eastern Europe was held on November 11th in the Jubilee

portion of the safety of patient improvement initiatives, hospital transfusion services report all the different hemovigilance happenings to federal, state, and non-governmental organizations (NGOs) [ 14 , 15 ]. In 2004, The Norwegian hemovigilance system initiated a system of reporting which is directed to professional and voluntary systems. In 2007, haemovigilance turned out to be the duty of an expert, according to the European Union (EU) blood instruction, and recording of serious adverse reactions (SARS) and serious adverse events (SAEs) grew into being obligatory